| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.005 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |